Bailey Jeffrey Allen

Average Profitability
34.43%
Insider Buys Quantity
5
Insider Buys Sum
$58,607.32
Insider Sells Quantity
1
Insider Sells Sum
$38,415.51

Insider Activity of Bailey Jeffrey Allen

According to the SEC Form 4 filings, Bailey Jeffrey Allen, being in a position of

  1. director at Aurinia Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 4557 shares for $38,416,
    over all time since 2024-11-11, has bought 0 shares, and sold 4557 shares for $38,416.

The largest purchase of all time was on 2019-11-15 and amounted to 39142 shares of Aileron Therapeutics, Inc. for $19,962.

The largest sale of all time was on 2024-11-11 and amounted to 4557 shares of Aurinia Pharmaceuticals Inc. for $38,416.

Biography of Bailey Jeffrey Allen

No biography is available at this moment.

2024-11-11SaleAurinia Pharmaceuticals Inc.
AUPH
director
4,557
0.0032%
$8.43$38,416+4.48%
2020-09-23PurchaseTekla Healthcare Investors
HQH
director
490
0.0012%
$20.39$9,991+26.68%
2020-09-22PurchaseTekla Life Sciences Investors
HQL
director
580
0.0026%
$17.28$10,022+20.32%
2019-11-15PurchaseAileron Therapeutics, Inc.
ALRN
director
39,142
0.1624%
$0.51$19,962+60.68%
2019-11-14PurchaseAileron Therapeutics, Inc.
ALRN
director
15,858
0.0646%
$0.51$8,088+57.84%
2019-11-12PurchaseAileron Therapeutics, Inc.
ALRN
director
19,894
0.0805%
$0.53$10,544+50.37%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.